Medicare Coverage for Device Trials

Prior to enrolling ANY MEDICARE PATIENTS in an IDE or a Post-Market PTA with Carotid Stent Study, you must receive written approval for both Medicare Part A and Part B coverage (Facility and Provider). 

Use of an HDE device no longer requires a formal application to Medicare.  However, Medicare still has special HDE requirements that need to be completed prior to enrolling any Medicare patients.  Contact the CRCE office to discuss these requirements.


Compliance Risk for Improper Billing:

If required processes are not followed and/or approvals are not obtained in advance of submitting a claim to Noridian, Medicare's local contractor, the risks to both hospital and physician claims include:

  • No payment for services rendered
    • Payment denial
    • Denial may include up to the full hospital stay and pro-fees
    • Improper payment with subsequent repayment
  • Possible false claims risk


Required Informed Consent Language for Noridian IDE Submissions:

Noridian requires that the Informed Consent contain the suggested language in the approved document.

Suggested language: "The University of Utah Health Care and Principal Investigator receives 
funds from the sponsor, (enter sponsor name), to cover costs related to research."

Note: The suggested location of the above language may be entered in the “Background” section of the Informed Consent.


Medicare may provide reimbursement for some investigational devices and related services. Services may be furnished in preparation for device use, contemporaneously with, and necessary to the use of the device, and as follow-up care after device use. Coverage is contingent on the Medicare contractor's approval of the application for reimbursement. Our local Medicare Contractor is Noridian. For additional information please visit the following websites:

Next to IDE Coverage Application Steps

Next to HDE Coverage Inforamtion 

Next to Post-Market PTA with Carotid Stenting Application Steps

If you have questions contact: Kristin Kolsch, FDA Compliance Officer at (801)587-0835.